4.7 Article

Acetyl-CoA Acetyltransferase 2 Confers Radioresistance by Inhibiting Ferroptosis in Esophageal Squamous Cell Carcinoma

Related references

Note: Only part of the references are listed.
Article Oncology

Quantitative proteomic analysis of GnRH agonist treated GBM cell line LN229 revealed regulatory proteins inhibiting cancer cell proliferation

Priyanka H. Tripathi et al.

Summary: The study reveals that GnRH agonist can inhibit cell proliferation in GBM, affecting the expression of multiple proteins, with some novel proteins identified in the GnRH signaling pathway, such as KNG1 and AHSG. Further investigation suggests a potential link between GnRH and EGFR signaling pathways through KNG1.

BMC CANCER (2022)

Review Oncology

The Essentials of Multiomics

John L. Marshall et al.

Summary: This paper discusses the development and importance of multiomics in clinical practice, highlighting the knowledge gap within the medical community and urging physicians to actively adapt and prepare for this new era.

ONCOLOGIST (2022)

Review Oncology

Hallmarks of Cancer: New Dimensions

Douglas Hanahan

Summary: The concept of the hallmarks of cancer is a tool for simplifying the complexity of cancer phenotypes and genotypes into basic principles. This article proposes phenotypic plasticity and disrupted differentiation as distinct hallmark capabilities, and discusses nonmutational epigenetic reprogramming and polymorphic microbiomes as enabling characteristics. Additionally, the importance of senescent cells in the tumor microenvironment is highlighted. The integrative concept of the hallmarks of cancer helps in understanding the mechanisms of cancer development and applying that knowledge to cancer medicine.

CANCER DISCOVERY (2022)

Article Biochemistry & Molecular Biology

AKT serine/threonine kinase 2-mediated phosphorylation of fascin threonine 403 regulates esophageal cancer progression

Zhi-Da Zhang et al.

Summary: In this study, we identified a novel phosphorylation site in Fascin and confirmed AKT2 as the kinase for this site. Phosphorylation of Fascin Threonine 403 suppresses the behavior of esophageal cancer cells, actin-bundling activity, and filopodia formation.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2022)

Review Oncology

Recent Advances in Combination of Immunotherapy and Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma

Ruixi Wang et al.

Summary: Combining immunotherapy with chemoradiotherapy is a new treatment option for locally advanced esophageal squamous cell carcinoma (ESCC), but further research is needed. Valid biomarkers are also needed to predict tumor response and survival outcomes.

CANCERS (2022)

Article Oncology

STAT3β disrupted mitochondrial electron transport chain enhances chemosensitivity by inducing pyroptosis in esophageal squamous cell carcinoma

Zhen-Yuan Zheng et al.

Summary: The study reveals that high expression of STAT3 beta enhances chemotherapy sensitivity and pyroptosis in ESCC cells after cisplatin treatment by disrupting the mitochondrial electron transport chain. Clinical significance shows that high expression of both STAT3 beta and GSDME is associated with better survival outcomes in ESCC patients.

CANCER LETTERS (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Review Biochemistry & Molecular Biology

An update on the function and regulation of methylerythritol phosphate and mevalonate pathways and their evolutionary dynamics

Xiaojun Pu et al.

Summary: Isoprenoids are a diverse class of organic compounds involved in photosynthesis, respiration, growth, development, and stress responses in plants. The mevalonate (MVA) and methylerythritol phosphate (MEP) pathways play key roles in isoprenoid synthesis and plant growth, development, and stress responses. The emergence of the MVA pathway is a crucial evolutionary event in plants, facilitating land colonization, embryo development, and adaptation to new environments.

JOURNAL OF INTEGRATIVE PLANT BIOLOGY (2021)

Review Oncology

Broadening horizons: the role of ferroptosis in cancer

Xin Chen et al.

Summary: Ferroptosis is an iron-dependent form of regulated cell death driven by excessive lipid peroxidation, and can be induced by various agents to suppress tumor growth while also potentially triggering inflammation-associated immunosuppression. The extent of ferroptosis's impact on tumor biology and its interactions with other signaling pathways are still under investigation.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

Article Multidisciplinary Sciences

PGRMC1 acts as a size-selective cargo receptor to drive ER-phagic clearance of mutant prohormones

Yu-Jie Chen et al.

Summary: The degradation of misfolded proteins from the endoplasmic reticulum is crucial for cellular protein homeostasis. The ER membrane protein PGRMC1 binds to misfolded prohormones and targets them for degradation through the ER-phagy pathway. This finding suggests that PGRMC1 could be a potential therapeutic target for diabetes.

NATURE COMMUNICATIONS (2021)

Article Oncology

STAT3β Enhances Sensitivity to Concurrent Chemoradiotherapy by Inducing Cellular Necroptosis in Esophageal Squamous Cell Carcinoma

Zhen-Yuan Zheng et al.

Summary: The study found that ESCC patients with high STAT3 beta expression have a better survival rate and complete response to concurrent chemoradiotherapy. High expression of STAT3 beta may enhance sensitivity to CCRT by regulating gene expression and inducing necrotic cell death.

CANCERS (2021)

Article Biotechnology & Applied Microbiology

Simvastatin induced ferroptosis for triple-negative breast cancer therapy

Xianxian Yao et al.

Summary: Triple-negative breast cancer (TNBC) presents a challenge in terms of effective treatment. The use of ferroptosis as a novel cell death mechanism is showing promise in treating TNBC cells. The development of a ferroptosis nanomedicine using SIM loaded nanoparticles demonstrates enhanced therapeutic effects against TNBC cells.

JOURNAL OF NANOBIOTECHNOLOGY (2021)

Article Biotechnology & Applied Microbiology

Targeting cholesterol biosynthesis promotes anti-tumor immunity by inhibiting long noncoding RNA SNHG29-mediated YAP activation

Wen Ni et al.

Summary: Research has shown that simvastatin inhibits PD-L1 expression and promotes anti-tumor immunity by suppressing the expression of lncRNA SNHG29. SNHG29 interacts with YAP and inhibits its degradation, leading to the downregulation of PD-L1.

MOLECULAR THERAPY (2021)

Article Medicine, General & Internal

Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer

Ronan J. Kelly et al.

Summary: In patients with resected esophageal or gastroesophageal junction cancer who had received neoadjuvant chemoradiotherapy, adjuvant therapy with nivolumab significantly improved disease-free survival compared to placebo.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Review Cell Biology

Ferroptosis, radiotherapy, and combination therapeutic strategies

Guang Lei et al.

Summary: Ferroptosis, an iron-dependent form of regulated cell death, plays an important role in radiotherapy-induced cell death and tumor suppression, mediating synergy with immunotherapy. This review summarizes the crosstalk between radiotherapy and ferroptosis, and explores combination therapeutic strategies.

PROTEIN & CELL (2021)

Review Oncology

Statins: a repurposed drug to fight cancer

Wen Jiang et al.

Summary: Statins, as HMG-CoA reductase inhibitors, not only lower cholesterol and improve cardiovascular risk, but also show potential as anti-cancer drugs. However, evidence on their anti-cancer efficacy is inconsistent, with further research needed to determine if they are more effective against certain molecular subtypes of cancer.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)

Review Oncology

Current status and application of proton therapy for esophageal cancer

Xin Wang et al.

Summary: Esophageal cancer remains a leading cause of cancer death globally. While early-stage disease can be surgically treated, locally advanced disease is typically managed with concurrent chemoradiation, with proton therapy showing potential benefits in reducing complications and improving survival outcomes.

RADIOTHERAPY AND ONCOLOGY (2021)

Article Multidisciplinary Sciences

Large-scale and high-resolution mass spectrometry-based proteomics profiling defines molecular subtypes of esophageal cancer for therapeutic targeting

Wei Liu et al.

Summary: Proteomic analysis identified two molecular subtypes of esophageal cancer, with the S2 subtype being more aggressive and associated with a potential therapeutic outlook provided by a subtype diagnostic and prognostic model.

NATURE COMMUNICATIONS (2021)

Review Gastroenterology & Hepatology

Targeting hallmarks of cancer to enhance radiosensitivity in gastrointestinal cancers

Amy M. Buckley et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)

Review Cell Biology

Emerging Mechanisms and Disease Relevance of Ferroptosis

Brent R. Stockwell et al.

TRENDS IN CELL BIOLOGY (2020)

Review Cell Biology

The Metabolic Underpinnings of Ferroptosis

Jiashuo Zheng et al.

CELL METABOLISM (2020)

Review Biochemical Research Methods

Proteogenomic examination of esophageal squamous cell carcinoma (ESCC): new lines of inquiry

Shobha Dagamajalu et al.

EXPERT REVIEW OF PROTEOMICS (2020)

Article Multidisciplinary Sciences

Squalene accumulation in cholesterol auxotrophic lymphomas prevents oxidative cell death

Javier Garcia-Bermudez et al.

NATURE (2019)

Article Multidisciplinary Sciences

FSP1 is a glutathione-independent ferroptosis suppressor

Sebastian Doll et al.

NATURE (2019)

Review Oncology

The Reciprocity between Radiotherapy and Cancer Immunotherapy

Yifan Wang et al.

CLINICAL CANCER RESEARCH (2019)

Review Cell Biology

Ferroptosis, a new form of cell death, and its relationships with tumourous diseases

Haitao Yu et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2017)

Article Biochemical Research Methods

Label-free quantitative proteomic analysis of Lactobacillus fermenturn NCDC 400 during bile salt exposure

Gurjeet Kaur et al.

JOURNAL OF PROTEOMICS (2017)

Article Multidisciplinary Sciences

Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway

Vasanthi S. Viswanathan et al.

NATURE (2017)

Review Biochemistry & Molecular Biology

Mevalonate Pathway and Human Cancers

Seyedeh Zahra Bathaie et al.

CURRENT MOLECULAR PHARMACOLOGY (2017)

Article Biochemistry & Molecular Biology

Global survey of cell death mechanisms reveals metabolic regulation of ferroptosis

Kenichi Shimada et al.

NATURE CHEMICAL BIOLOGY (2016)

Article Gastroenterology & Hepatology

Recent Advances From Basic and Clinical Studies of Esophageal Squamous Cell Carcinoma

Shinya Ohashi et al.

GASTROENTEROLOGY (2015)

Article Biochemistry & Molecular Biology

Identification of a novel lysyl oxidase-like 2 alternative splicing isoform, LOXL2 Δe13, in esophageal squamous cell carcinoma

Guo-Qing Lv et al.

BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE (2014)

Article Biochemical Research Methods

Proteomic workflow for analysis of archival formalin-fixed and paraffin-embedded clinical samples to a depth of 10 000 proteins

Jacek R. Wisniewski et al.

PROTEOMICS CLINICAL APPLICATIONS (2013)

Article Oncology

Prioteomic analysis of Waldenstrom macroglobulinemia

Evdoxia Hatjiharissi et al.

CANCER RESEARCH (2007)